Jonathan Becker
Psychiatry · Brentwood, TNNPI 1487897146
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,670, 4.8 times the $346 reported in 2021.
Across 260 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$972
- Johnson & Johnson$812
- Alkermes, Inc.$713
- Axsome Therapeutics, Inc.$695
- AbbVie$664
- Otsuka America Pharmaceutical, Inc.$350
- plus $2K from 16 others
Across 215 payments — averaging $1188.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$256K
What the payments were for
- Food & beverage$5,771100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $972 |
| Johnson & Johnson | 36 | $812 |
| Alkermes, Inc. | 31 | $713 |
| Axsome Therapeutics, Inc. | 29 | $695 |
| AbbVie | 40 | $664 |
| Otsuka America Pharmaceutical, Inc. | 16 | $350 |
| Livanova USA, Inc. | 5 | $311 |
| Neurocrine Biosciences, Inc. | 9 | $204 |
| Vanda Pharmaceuticals Inc. | 7 | $177 |
| Lundbeck LLC | 8 | $156 |
| Noven Therapeutics, LLC | 8 | $149 |
| E.r. Squibb & Sons, L.L.C. | 5 | $129 |
| Idorsia Pharmaceuticals US Inc | 7 | $118 |
| Jazz Pharmaceuticals Inc. | 3 | $60 |
| Tempus AI, Inc | 2 | $59 |
| Sunovion Pharmaceuticals Inc. | 2 | $51 |
| Bausch Health US, LLC | 2 | $46 |
| Neos Therapeutics, LP | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Corium, LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Brainsway USA Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,783 in reported general payments places this provider in the 85th percentile of 503 psychiatry providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $298 |
| Alprazolam | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Brentwood
- Richard RochesterBrentwood$7K
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- John FenleyJohnson City$1.4M
- David SnowMaryville$605K
- Karthi NamasivayamKnoxville$225K
- Robert JamiesonNashville$141K
- George BrownJohnson City$91K
- Sricharan MoturiFranklin$82K
- Michelle CochranNashville$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.